Medical device company MicroPort Orthopedics has launched its EVOLUTION Revision tibial system and EVOLUTION BioFoam tibia.

Designed by surgeons from Europe, Asia, Canada and the US, the new tibial system is a revised version of the firm's Medial-Pivot knee system.

The revised system is expected to provide intra-operative flexibility for individual anatomic patient needs, such as fixation problems due to poor bone stock, and maintain the kinematic benefits of the Medial-Pivot.

MicroPort Orthopedics president Aurelio Sahagun said: “MicroPort Orthopedics continues to grow its product portfolio with a steady cadence of product launches.

“These product launches demonstrate our commitment to help improve patient outcomes by giving surgeons a broad array of choices that allow them to treat their patients."

“These product launches demonstrate our commitment to help improve patient outcomes by giving surgeons a broad array of choices that allow them to treat their patients.

"We are excited to bring the benefits of the Medial-Pivot design to a revision system.”

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The new BioFoam tibia is launched as a part of the EVOLUTION Medial-Pivot cement-less system to complement the existing EVOLUTION porous femoral component.

Based on the existing ADVANCE BioFoam tibia, the new device is designed to combine the Medial-Pivot benefits and the early fixation advantages, while meeting the long-term demands of young and active patients.

The ADVANCE BioFoam tibia is reported to have 98% survivorship at two years.

Based in Tennessee, US, MicroPort Orthopedics develops, produces and distributes orthopaedic reconstructive products.

Its US manufacturing and logistics capabilities provide hip and knee products in more than 60 markets, such as EMEA, Japan, Latin America and China.